Anemia in CKD

The recent meta analysis published in Lancet clarifies that need for erythropoetin is so controversial, especially with outcomes showing more mortality in higher Hb concentrations. It would be worthwile to analyze the data from Indian hospitals where economic burden for use of EPO limits it's use.